Naproxen/pseudoephedrine - Beijing CoSci Med TechAlternative Names: Pseudoephedrine/naproxen
Latest Information Update: 25 Jul 2016
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antipyretics; Antirheumatics; Decongestants; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Cyclooxygenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Common cold
Most Recent Events
- 25 Jul 2016 Investigation in Common cold in China (PO)